Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Proactive Versus Reactive Strategies
DOI:
https://doi.org/10.5281/zenodo.22649043Keywords:
Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease, Translational medicine; Evidence synthesis;, Clinical implementation; Health services researchAbstract
Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease is an area of active development in translational
medicine, with evidence that has accumulated unevenly across its component questions. We review the current evidence base for
therapeutic drug monitoring of biologics in inflammatory bowel disease, spanning analytical, clinical, implementation,
governance, and economic dimensions, focusing on where practice has converged and where it continues to vary, and set out the
practical considerations relevant to a service considering its adoption. We conclude that selective, context-specific use is best
supported by the evidence currently available, rather than uniform adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.3389/fdgth.2026.1834800
Brankovic K, Kowalczyk B, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.2196/69678
Castellani R, Ristic C, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.7759/cureus.46454
Dumitrescu A, Andric D, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.1016/j.ssci.2025.107028
Eriksdottir B, Brankovic E, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.2196/48633
Farkas I, Ionescu F, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.1371/journal.pone.0305949
Grabowski P, Petrescu G, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.1371/journal.pdig.0000514
Hendriksen W, Wojcik H, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.17219/acem/208596
Ionescu F, Foscarini I, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI:
7759/cureus.104086 10. Jankowiak G, Grabowski J, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.1038/s41746-023-00852-5
Kowalczyk N, Novotna K, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.1016/j.mayocpiqo.2022.09.004
Lindqvist U, Urbanek L, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.1177/08404704241291226
Marchetti D, Doncheva M, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1093/medlaw/fwad013
Novotna E, Eriksdottir N, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.2196/89834
Ostrowski L, Lindqvist O, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.1007/s10916-024-02104-9
Petrescu S, Szabo P, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.3389/fdgth.2026.1896184
Quintero B, Balogh Q, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.3390/diagnostics15162117
Ristic C, Castellani R, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.4103/jrpp.jrpp_20_65
Szabo J, Jankowiak S, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.3389/fdgth.2026.1763884
Tarasov Q, Quintero T, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.2196/48297
Urbanek Z, Zielinski U, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.1007/s00330-025-12031-z
Vasquez A, Alvez V, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.3389/fdgth.2026.1699005
Wojcik H, Hendriksen W, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.3389/fdgth.2026.1834800
Zielinski O, Ostrowski Z, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.2196/69678
Andric V, Vasquez A, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.7759/cureus.46454
Balogh E, Emmerich B, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.1016/j.ssci.2025.107028
Chiriac F, Farkas C, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.2196/48633
Doncheva M, Marchetti D, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a validation study". Trials 22(2017): 377-383. DOI: 10.1371/journal.pone.0305949
Emmerich T, Tarasov E, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.1371/journal.pdig.0000514
Foscarini C, Chiriac F, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.17219/acem/208596
Alvez D, Dumitrescu A, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.7759/cureus.104086
Brankovic K, Kowalczyk B, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.1038/s41746-023-00852-5
Castellani R, Ristic C, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.1016/j.mayocpiqo.2022.09.004
Dumitrescu A, Andric D, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.1177/08404704241291226
Eriksdottir B, Brankovic E, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1093/medlaw/fwad013
Farkas I, Ionescu F, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.2196/89834
Grabowski P, Petrescu G, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.1007/s10916-024-02104-9
Hendriksen W, Wojcik H, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.3389/fdgth.2026.1896184
Ionescu F, Foscarini I, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a scoping review". JAMA 44(2020): 498-506. DOI: 10.3390/diagnostics15162117
Jankowiak G, Grabowski J, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.4103/jrpp.jrpp_20_65
Kowalczyk N, Novotna K, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.3389/fdgth.2026.1763884
Lindqvist U, Urbanek L, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.2196/48297
Marchetti D, Doncheva M, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.1007/s00330-025-12031-z
Novotna E, Eriksdottir N, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.3389/fdgth.2026.1699005
Ostrowski L, Lindqvist O, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.3389/fdgth.2026.1834800
Petrescu S, Szabo P, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.2196/69678
Quintero B, Balogh Q, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.7759/cureus.46454
Ristic C, Castellani R, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.1016/j.ssci.2025.107028
Szabo J, Jankowiak S, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.2196/48633
Tarasov Q, Quintero T, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.1371/journal.pone.0305949
Urbanek Z, Zielinski U, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.1371/journal.pdig.0000514
Vasquez A, Alvez V, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.17219/acem/208596
Wojcik H, Hendriksen W, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a multicentre analysis". Drug Discov Today 32(2017): 652-665. 10.7759/cureus.104086
Zielinski O, Ostrowski Z, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. 10.1038/s41746-023-00852-5
Andric V, Vasquez A, et al. "Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: a randomised evaluation". BMJ Open 36(2023): 674-680. 10.1016/j.mayocpiqo.2022.09.004
